CARDURA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cardura, and when can generic versions of Cardura launch?
Cardura is a drug marketed by Viatris and is included in two NDAs.
The generic ingredient in CARDURA is doxazosin mesylate. There are fourteen drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the doxazosin mesylate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cardura
A generic version of CARDURA was approved as doxazosin mesylate by APOTEX on October 18th, 2000.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CARDURA?
- What are the global sales for CARDURA?
- What is Average Wholesale Price for CARDURA?
Summary for CARDURA
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 106 |
Clinical Trials: | 11 |
Patent Applications: | 1,730 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for CARDURA |
What excipients (inactive ingredients) are in CARDURA? | CARDURA excipients list |
DailyMed Link: | CARDURA at DailyMed |
![CARDURA drug patent expirations Drug patent expirations by year for CARDURA](/p/graph/s/t/CARDURA-patent-expirations.png)
![Drug Prices for CARDURA](/p/graph/drug-price/CARDURA.png)
![Drug Sales Revenue Trends for CARDURA](/p/graph/drug-sales-revenues/CARDURA.png)
Recent Clinical Trials for CARDURA
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
The University of Texas Health Science Center, Houston | Phase 1 |
Brown University | Phase 2 |
University of California, Los Angeles | Phase 3 |
Pharmacology for CARDURA
Drug Class | alpha-Adrenergic Blocker |
Mechanism of Action | Adrenergic alpha-Antagonists |
US Patents and Regulatory Information for CARDURA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Viatris | CARDURA | doxazosin mesylate | TABLET;ORAL | 019668-001 | Nov 2, 1990 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Viatris | CARDURA | doxazosin mesylate | TABLET;ORAL | 019668-004 | Nov 2, 1990 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Viatris | CARDURA | doxazosin mesylate | TABLET;ORAL | 019668-002 | Nov 2, 1990 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Viatris | CARDURA | doxazosin mesylate | TABLET;ORAL | 019668-003 | Nov 2, 1990 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Viatris | CARDURA XL | doxazosin mesylate | TABLET, EXTENDED RELEASE;ORAL | 021269-002 | Feb 22, 2005 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Viatris | CARDURA XL | doxazosin mesylate | TABLET, EXTENDED RELEASE;ORAL | 021269-001 | Feb 22, 2005 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CARDURA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Viatris | CARDURA | doxazosin mesylate | TABLET;ORAL | 019668-001 | Nov 2, 1990 | ⤷ Sign Up | ⤷ Sign Up |
Viatris | CARDURA | doxazosin mesylate | TABLET;ORAL | 019668-003 | Nov 2, 1990 | ⤷ Sign Up | ⤷ Sign Up |
Viatris | CARDURA | doxazosin mesylate | TABLET;ORAL | 019668-002 | Nov 2, 1990 | ⤷ Sign Up | ⤷ Sign Up |
Viatris | CARDURA | doxazosin mesylate | TABLET;ORAL | 019668-004 | Nov 2, 1990 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for CARDURA
See the table below for patents covering CARDURA around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Netherlands | 930062 | ⤷ Sign Up | |
South Africa | 7806184 | ⤷ Sign Up | |
Denmark | 428678 | ⤷ Sign Up | |
Finland | 64366 | ⤷ Sign Up | |
Philippines | 13966 | PIPERAZINYL QUINAZOLINE DERIVATIVES AS ANTIHYPERTENSIVES | ⤷ Sign Up |
Kenya | 3350 | A-AMINO-2-(PIPERAZIN-1-YL OR HOMOPIPERAZIN-1-YL)QUINAZOLINE DERIVATIVES | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |